Advances in pharmacogenomics for the treatment of type 2 diabetes
10.3969/j.issn.1673-4130.2025.03.019
- VernacularTitle:2型糖尿病治疗药物的药物基因组学研究进展
- Author:
Yulong MA
1
;
Yalong LI
;
Xiaoxia HU
;
Gengxue JING
;
Xinyue LIU
Author Information
1. 兰州大学第二医院:检验医学中心,甘肃兰州 730000
- Keywords:
type 2 diabetes;
pharmacogenomics;
precision medicine
- From:
International Journal of Laboratory Medicine
2025;46(3):349-353
- CountryChina
- Language:Chinese
-
Abstract:
Hypoglycemic drugs are an important means of treatment for patients with type 2 diabetes.However,poor,ineffective and even adverse drug reactions often occur in clinical treatment.With the develop-ment of pharmacogenomics,the link between individual genetic variation and drug dose and treatment re-sponse is becoming clearer,resulting in better efficacy and fewer adverse reactions for patients.This article fo-cuses on hypoglycemic drugs and reviews the latest advances in pharmacogenomics,so as to provide references for individualized treatment of type 2 diabetes and prevention of corresponding complications until the realiza-tion of precision medicine
